Organigram CEO To Retire After Building Canada's Largest Cannabis Brand: Here's What's Next Organigram CEO Beena Goldenberg to retire after leading company to #1 in Canada and launching U.S. and global expansion plans.
Germany Has Become The World's Largest Cannabis Importer: Here Are The Stocks Benefiting Germany became the world's top importer of medical cannabis, but political pressure could challenge telehealth-driven growth.
Organigram Lights Up Q2 With 74% Sales Surge, Profitable Turn Organigram's Q2 sales surged 74% to $45.7 million, driven by Motif and global growth, with net income swinging to CA$42.5 million from a loss a year ago.
Why Pre-Rolls Are Cannabis' Most Profitable Format, From California To Canada Pre-rolls dominate cannabis sales on both sides of the border—but California and Canada are playing very different games to win.
This Week In Cannabis: Trump Policy Updates, Corporate Moves, Regulatory Shifts And Product Innovations This week in cannabis: major mergers, innovative launches, key regulatory updates & leadership changes drive industry transformation.
This Week In Cannabis: Gaetz's Stock Rally, Major Policy Battles, Homeland Security's Stance, Big Earnings And More Cannabis news this week: Gaetz sparks cannabis stock rally, Homeland Security reaffirms seizures, key policy moves and major earnings shake the industry.
Big Tobacco's Latest $86.8 Million Cannabis Investment Signals Growing Industry Influence British American Tobacco finalizes a C$124.6M investment in Organigram, reinforcing big tobacco's stake in cannabis.
Organigram (OGI) Q1 2025 Earnings Call Transcript OGI earnings call for the period ending December 31, 2024.
